Folic Acid Clinical Trial (FACT)

• Research type

  Research Study

• Full title

  Effect of folic acid supplementation in pregnancy on preeclampsia - Folic Acid Clinical Trial (FACT) A randomized, double-blind, placebo-controlled, Phase III, international multi-centre study of 4.0 mg of Folic Acid supplementation in pregnancy for the prevention of preeclampsia

• IRAS ID

  79194

• Contact name

  S C Robson

• Sponsor organisation

  Ottawa Hospital Research Institute

• Eudract number

  2012-001918-42

• ISRCTN Number

  ISRCTN23781770

• Clinicaltrials.gov Identifier

  NCT01355159

• Research summary

  This study is a randomised double blind placebo-controlled clinical trial to evaluate a new preeclampsia (PE) prevention strategy of a high dose supplement of folic acid (4mg) in early (8 0/7 to 16 6/7 weeks) pregnancy until delivery.

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  12/NE/0401

• Date of REC Opinion

  21 Dec 2012

• REC opinion

  Further Information Favourable Opinion